(+)-isolariciresinol decreases expression ISO PCSK9 (Homo sapiens) 6480464 isolariciresinol results in decreased expression of PCSK9 mRNA and isolariciresinol results in decreased expression of PCSK9 protein CTD PMID:35755389 (-)-epigallocatechin 3-gallate increases expression ISO PCSK9 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of PCSK9 mRNA CTD PMID:32512070 1,2-dichloroethane decreases expression ISO Pcsk9 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of PCSK9 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of PCSK9 mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression ISO Pcsk9 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of PCSK9 mRNA CTD PMID:22206623 1-(3-(trifluoromethyl)phenyl)piperazine increases expression EXP 6480464 1-(3-trifluoromethylphenyl)piperazine results in increased expression of PCSK9 mRNA CTD PMID:26821219 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of PCSK9 mRNA CTD PMID:26821219 1-chloro-2,4-dinitrobenzene affects binding ISO PCSK9 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to PCSK9 protein CTD PMID:32991956 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PCSK9 mRNA CTD PMID:30723492 17beta-estradiol decreases expression ISO PCSK9 (Homo sapiens) 6480464 Estradiol results in decreased expression of PCSK9 mRNA CTD PMID:20106945 and PMID:21632981 17beta-estradiol multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] results in increased expression of PCSK9 mRNA CTD PMID:32741896 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of PCSK9 mRNA CTD PMID:32145629 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl increases expression ISO PCSK9 (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PCSK9 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PCSK9 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pcsk9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PCSK9 mRNA CTD PMID:28238261 and PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO PCSK9 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PCSK9 mRNA CTD PMID:20106945 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO PCSK9 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of PCSK9 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCSK9 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane affects expression ISO Pcsk9 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane affects the expression of PCSK9 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of PCSK9 gene CTD PMID:31601247 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PCSK9 mRNA CTD PMID:24780913 acetaldehyde affects expression ISO Pcsk9 (Mus musculus) 6480464 Acetaldehyde affects the expression of PCSK9 mRNA CTD PMID:22634333 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PCSK9 mRNA CTD PMID:31881176 acetohydrazide increases expression ISO Pcsk9 (Mus musculus) 6480464 acetylhydrazine results in increased expression of PCSK9 mRNA CTD PMID:15282401 Actein increases expression EXP 6480464 actein results in increased expression of PCSK9 protein CTD PMID:29969672 aflatoxin B1 affects expression ISO PCSK9 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of PCSK9 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO PCSK9 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of PCSK9 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO PCSK9 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of PCSK9 mRNA CTD PMID:21632981 more ... aldehydo-D-glucose multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 aldrin increases expression ISO Pcsk9 (Mus musculus) 6480464 Aldrin results in increased expression of PCSK9 mRNA CTD PMID:18579281 amiodarone increases expression ISO PCSK9 (Homo sapiens) 6480464 Amiodarone results in increased expression of PCSK9 mRNA CTD PMID:19774075 arsenous acid decreases expression ISO PCSK9 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of PCSK9 mRNA CTD PMID:26705709 avobenzone increases expression ISO PCSK9 (Homo sapiens) 6480464 avobenzone results in increased expression of PCSK9 mRNA CTD PMID:31016361 belinostat decreases expression ISO PCSK9 (Homo sapiens) 6480464 belinostat results in decreased expression of PCSK9 mRNA CTD PMID:27188386 benzalkonium chloride decreases expression ISO Pcsk9 (Mus musculus) 6480464 Benzalkonium Compounds results in decreased expression of PCSK9 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression ISO Pcsk9 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PCSK9 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO PCSK9 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of PCSK9 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO PCSK9 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PCSK9 intron and Benzo(a)pyrene affects the methylation of PCSK9 promoter CTD PMID:27901495 and PMID:30157460 benzo[a]pyrene decreases expression ISO PCSK9 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PCSK9 mRNA CTD PMID:20106945 more ... beta-naphthoflavone decreases expression ISO Pcsk9 (Mus musculus) 6480464 beta-Naphthoflavone results in decreased expression of PCSK9 mRNA CTD PMID:22234961 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PCSK9 mRNA CTD PMID:18164116 beta-naphthoflavone multiple interactions ISO Pcsk9 (Mus musculus) 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of PCSK9 mRNA] CTD PMID:22234961 bezafibrate increases expression ISO PCSK9 (Homo sapiens) 6480464 Bezafibrate results in increased expression of PCSK9 protein CTD PMID:21411093 bis(2-ethylhexyl) phthalate decreases expression ISO PCSK9 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of PCSK9 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PCSK9 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO Pcsk9 (Mus musculus) 6480464 bisphenol A results in increased expression of PCSK9 mRNA and bisphenol A results in increased expression of PCSK9 protein CTD PMID:33221593 and PMID:35999755 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PCSK9 mRNA CTD PMID:32145629 bisphenol A affects expression ISO PCSK9 (Homo sapiens) 6480464 bisphenol A affects the expression of PCSK9 mRNA CTD PMID:30903817 bisphenol A affects methylation ISO Pcsk9 (Mus musculus) 6480464 bisphenol A affects the methylation of PCSK9 promoter CTD PMID:27334623 bisphenol A multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCSK9 mRNA CTD PMID:28628672 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of PCSK9 mRNA CTD PMID:32479839 butan-1-ol multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PCSK9 mRNA CTD PMID:29432896 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of PCSK9 mRNA CTD PMID:25868845 caffeine increases phosphorylation ISO PCSK9 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of PCSK9 protein CTD PMID:35688186 carbamazepine decreases expression ISO PCSK9 (Homo sapiens) 6480464 Carbamazepine results in decreased expression of PCSK9 mRNA CTD PMID:21123845 carbon nanotube increases expression ISO PCSK9 (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of PCSK9 mRNA CTD PMID:24389112 carbon nanotube decreases expression ISO Pcsk9 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO PCSK9 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to PCSK9 gene] CTD PMID:28238834 chloroethene increases expression ISO Pcsk9 (Mus musculus) 6480464 Vinyl Chloride results in increased expression of PCSK9 mRNA CTD PMID:18579281 ciguatoxin CTX1B affects expression ISO Pcsk9 (Mus musculus) 6480464 Ciguatoxins affects the expression of PCSK9 mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PCSK9 mRNA CTD PMID:22023808 cobalt dichloride decreases secretion ISO PCSK9 (Homo sapiens) 6480464 cobaltous chloride results in decreased secretion of PCSK9 protein CTD PMID:22079246 copper atom multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of PCSK9 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of PCSK9 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO PCSK9 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of PCSK9 mRNA CTD PMID:19549813 copper(II) sulfate increases expression ISO Pcsk9 (Mus musculus) 6480464 Copper Sulfate results in increased expression of PCSK9 mRNA CTD PMID:18579281 curcumin affects expression ISO Pcsk9 (Mus musculus) 6480464 Curcumin affects the expression of PCSK9 mRNA CTD PMID:27208389 cyclosporin A decreases expression ISO PCSK9 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PCSK9 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression ISO PCSK9 (Homo sapiens) 6480464 Cyclosporine results in increased expression of PCSK9 mRNA CTD PMID:27989131 D-glucose multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 dexamethasone multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCSK9 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO PCSK9 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of PCSK9 mRNA CTD PMID:26705709 diclofenac increases expression ISO Pcsk9 (Mus musculus) 6480464 Diclofenac results in increased expression of PCSK9 mRNA CTD PMID:26934552 dimethylarsinic acid multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA CTD PMID:34876320 dorsomorphin multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PCSK9 mRNA CTD PMID:32289291 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PCSK9 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Pcsk9 (Mus musculus) 6480464 epoxiconazole results in decreased expression of PCSK9 mRNA CTD PMID:35436446 ethanol affects expression ISO Pcsk9 (Mus musculus) 6480464 Ethanol affects the expression of PCSK9 mRNA CTD PMID:30319688 ezetimibe multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [Simvastatin co-treated with Ezetimibe] results in increased expression of PCSK9 mRNA CTD PMID:17980884 fenofibrate increases expression ISO PCSK9 (Homo sapiens) 6480464 Fenofibrate results in increased expression of PCSK9 protein CTD PMID:21411093 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of PCSK9 mRNA CTD PMID:28263823 fluvastatin multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin CTD PMID:19773416 fructose multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 fulvestrant multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of PCSK9 gene CTD PMID:31601247 Ganoderic acid A decreases expression ISO PCSK9 (Homo sapiens) 6480464 ganoderic acid A results in decreased expression of PCSK9 mRNA CTD PMID:29852127 gemcitabine increases expression ISO PCSK9 (Homo sapiens) 6480464 Gemcitabine results in increased expression of PCSK9 mRNA CTD PMID:17039268 genistein decreases expression ISO Pcsk9 (Mus musculus) 6480464 Genistein results in decreased expression of PCSK9 mRNA CTD PMID:32186404 glafenine increases expression EXP 6480464 Glafenine results in increased expression of PCSK9 mRNA CTD PMID:24136188 glucose multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 glutathione decreases expression EXP 6480464 Glutathione deficiency results in decreased expression of PCSK9 mRNA CTD PMID:20621112 herbicide multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PCSK9 mRNA CTD PMID:37567420 hydrazine increases expression ISO Pcsk9 (Mus musculus) 6480464 hydrazine results in increased expression of PCSK9 mRNA CTD PMID:15282401 indometacin multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCSK9 mRNA CTD PMID:28628672 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of PCSK9 mRNA CTD PMID:28263823 L-ascorbic acid decreases expression ISO PCSK9 (Homo sapiens) 6480464 Ascorbic Acid results in decreased expression of PCSK9 mRNA and Ascorbic Acid results in decreased expression of PCSK9 protein CTD PMID:32913121 L-ascorbic acid decreases expression ISO Pcsk9 (Mus musculus) 6480464 Ascorbic Acid results in decreased expression of PCSK9 mRNA and Ascorbic Acid results in decreased expression of PCSK9 protein CTD PMID:32913121 L-ascorbic acid multiple interactions ISO PCSK9 (Homo sapiens) 6480464 FOXO3 protein affects the reaction [Ascorbic Acid results in decreased expression of PCSK9 protein] CTD PMID:32913121 L-ascorbic acid multiple interactions ISO Pcsk9 (Mus musculus) 6480464 Ascorbic Acid affects the reaction [GULO protein affects the expression of PCSK9 protein] and Ascorbic Acid results in decreased expression of and results in decreased secretion of PCSK9 protein CTD PMID:32913121 lipopolysaccharide increases expression ISO Pcsk9 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of PCSK9 mRNA CTD PMID:18638454 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of PCSK9 mRNA CTD PMID:28801915 mercury dibromide decreases expression ISO PCSK9 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of PCSK9 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK9 mRNA CTD PMID:27188386 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of PCSK9 mRNA CTD PMID:32599119 methylarsonic acid multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA CTD PMID:34876320 methylmercury chloride affects expression ISO Pcsk9 (Mus musculus) 6480464 methylmercuric chloride affects the expression of PCSK9 mRNA CTD PMID:21613230 methylmercury chloride decreases expression ISO PCSK9 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of PCSK9 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PCSK9 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PCSK9 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO Pcsk9 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of PCSK9 mRNA CTD PMID:24535843 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of PCSK9 mRNA CTD PMID:19638242 N-Nitrosopyrrolidine decreases expression ISO PCSK9 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of PCSK9 mRNA CTD PMID:32234424 O-methyleugenol decreases expression ISO PCSK9 (Homo sapiens) 6480464 methyleugenol results in decreased expression of PCSK9 mRNA CTD PMID:32234424 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of PCSK9 mRNA CTD PMID:23665939 p-chloromercuribenzoic acid decreases expression ISO PCSK9 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of PCSK9 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK9 mRNA CTD PMID:27188386 paracetamol decreases expression ISO PCSK9 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PCSK9 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PCSK9 mRNA CTD PMID:32479839 paracetamol increases expression ISO Pcsk9 (Mus musculus) 6480464 Acetaminophen results in increased expression of PCSK9 mRNA CTD PMID:29246445 paracetamol multiple interactions ISO Pcsk9 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of PCSK9 mRNA] CTD PMID:29246445 PCB138 multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentachlorophenol increases expression ISO Pcsk9 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of PCSK9 mRNA CTD PMID:23892564 perfluorononanoic acid decreases expression ISO PCSK9 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of PCSK9 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO PCSK9 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of PCSK9 protein CTD PMID:26879310 phenylmercury acetate decreases expression ISO PCSK9 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of PCSK9 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK9 mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO PCSK9 (Homo sapiens) 6480464 pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mRNA] CTD PMID:22593575 pioglitazone increases expression ISO Pcsk9 (Mus musculus) 6480464 pioglitazone results in increased expression of PCSK9 protein CTD PMID:22593575 pioglitazone multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [pioglitazone co-treated with U 0126] results in increased secretion of PCSK9 protein CTD PMID:22593575 pioglitazone increases expression ISO PCSK9 (Homo sapiens) 6480464 pioglitazone results in increased expression of PCSK9 mRNA and pioglitazone results in increased expression of PCSK9 protein CTD PMID:22593575 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of PCSK9 mRNA CTD PMID:27225895 pravastatin increases expression ISO Pcsk9 (Mus musculus) 6480464 Pravastatin results in increased expression of PCSK9 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression ISO Pcsk9 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of PCSK9 mRNA CTD PMID:28903501 quercetin decreases expression ISO PCSK9 (Homo sapiens) 6480464 Quercetin results in decreased expression of PCSK9 mRNA CTD PMID:21632981 resveratrol increases expression ISO PCSK9 (Homo sapiens) 6480464 resveratrol results in increased expression of PCSK9 mRNA CTD PMID:22153697 rotenone affects expression EXP 6480464 Rotenone affects the expression of PCSK9 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression ISO Pcsk9 (Mus musculus) 6480464 senecionine results in decreased expression of PCSK9 protein CTD PMID:35357534 silicon dioxide decreases expression ISO PCSK9 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of PCSK9 mRNA CTD PMID:25895662 silver atom decreases expression ISO PCSK9 (Homo sapiens) 6480464 Silver results in decreased expression of PCSK9 mRNA CTD PMID:26014281 silver(0) decreases expression ISO PCSK9 (Homo sapiens) 6480464 Silver results in decreased expression of PCSK9 mRNA CTD PMID:26014281 simvastatin multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [Simvastatin co-treated with Ezetimibe] results in increased expression of PCSK9 mRNA CTD PMID:17980884 sodium arsenate multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO Pcsk9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO Pcsk9 (Mus musculus) 6480464 sodium arsenite results in increased expression of PCSK9 mRNA CTD PMID:36209798 sulindac sulfide decreases expression ISO PCSK9 (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of PCSK9 mRNA CTD PMID:16184548 tamoxifen decreases expression ISO Pcsk9 (Mus musculus) 6480464 Tamoxifen results in decreased expression of PCSK9 mRNA CTD PMID:25123088 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] results in increased expression of PCSK9 mRNA CTD PMID:32741896 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of PCSK9 mRNA CTD PMID:34492290 trichloroethene decreases expression ISO Pcsk9 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of PCSK9 mRNA CTD PMID:25549359 trichostatin A decreases expression ISO PCSK9 (Homo sapiens) 6480464 trichostatin A results in decreased expression of PCSK9 mRNA CTD PMID:24935251 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of PCSK9 mRNA CTD PMID:30589522 Triptolide decreases expression ISO Pcsk9 (Mus musculus) 6480464 triptolide results in decreased expression of PCSK9 mRNA CTD PMID:32835833 tris(2-butoxyethyl) phosphate affects expression ISO PCSK9 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of PCSK9 mRNA CTD PMID:29024780 troglitazone decreases expression ISO PCSK9 (Homo sapiens) 6480464 troglitazone results in decreased expression of PCSK9 mRNA CTD PMID:25572481 valproic acid affects expression ISO Pcsk9 (Mus musculus) 6480464 Valproic Acid affects the expression of PCSK9 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO PCSK9 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK9 mRNA CTD PMID:27188386 valproic acid decreases expression ISO PCSK9 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PCSK9 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO PCSK9 (Homo sapiens) 6480464 Valproic Acid affects the expression of PCSK9 mRNA CTD PMID:25979313 Yessotoxin increases expression ISO PCSK9 (Homo sapiens) 6480464 yessotoxin analog results in increased expression of PCSK9 mRNA CTD PMID:30679557 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of PCSK9 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO Pcsk9 (Mus musculus) 6480464 squalestatin 1 results in increased expression of PCSK9 mRNA CTD PMID:27225895 zoledronic acid increases expression ISO PCSK9 (Homo sapiens) 6480464 zoledronic acid results in increased expression of PCSK9 mRNA CTD PMID:24714768